The only place Ziv is referred to in the report is
Post# of 15624
(Total Views: 290)
Posted On: 04/17/2017 11:31:24 PM
The only place Ziv is referred to in the report is in Note 13: Related Party Transaction:
3. Former Managing Director of the subsidiary, received compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years
On page 70, it looks like Mordechai Bignitz is assuming both roles. I think for now this is positive!
Our Board of Directors believes that Mr. Bignitz’s service as both the Chairman of our Board of Directors and our Chief Executive Officer is in the best interest of our Company and our stockholders. Mr. Bignitz possesses detailed and in-depth knowledge of the issues, opportunities and challenges facing our Company and our business and, therefore, is best positioned to develop agendas that ensure that the Board of Directors’ time and attention are focused on the most important matters.
3. Former Managing Director of the subsidiary, received compensation of $3,000 per month. In addition, he was awarded 10,000,000 options through the 2016 ESOP which vest over two years
On page 70, it looks like Mordechai Bignitz is assuming both roles. I think for now this is positive!
Our Board of Directors believes that Mr. Bignitz’s service as both the Chairman of our Board of Directors and our Chief Executive Officer is in the best interest of our Company and our stockholders. Mr. Bignitz possesses detailed and in-depth knowledge of the issues, opportunities and challenges facing our Company and our business and, therefore, is best positioned to develop agendas that ensure that the Board of Directors’ time and attention are focused on the most important matters.
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼